Alzheimer's Disease
|2 min read
Study Finds Major Performance Differences Among p-Tau217 Blood Tests
A multicenter study comparing nine plasma p-tau217 assays found substantial differences in diagnostic performance, highlighting the need for platform-specific calibration before clinical use
|2 min read
Anthem Policy Opens Reimbursement Path for Alzheimer’s Blood Tests
The insurer’s new medical-necessity criteria could improve payment prospects for laboratories offering several clinically validated biomarker assays
|2 min read
Huntington’s Researcher Chose Not to Take the Genetic Test She Helped Create
Clinical labs may find themselves facing patients with similar dilemmas, such as with Alzheimer's testing
|2 min read
Abbott, ALZpath Expand Push Toward Routine Blood-Based Alzheimer's Testing
Agreement brings pTau217 biomarker technology to Abbott's Alinity platform for blood-based Alzheimer's test development
Updated |3 min read
Blood-Based Biomarkers Are Transforming the Diagnosis of Alzheimer’s Disease
Real-world validation continues to reinforce the utility of blood-based biomarkers in Alzheimer’s disease for earlier and more accurate diagnosis
|3 min read
Texas Children’s Launches Large-Scale Open Drug Discovery Platform for Alzheimer’s Therapies
The NIH-funded initiative combines high-throughput screening and AI, giving global researchers access to one of the largest Alzheimer’s discovery datasets
|4 min read
Counting Down to Alzheimer’s Disease
FNIH’s Alessio Travaglia, PhD, discusses the new predictive “clock” model for Alzheimer’s disease
|2 min read
Study Shows Blood Test Can Predict Onset of Alzheimer’s Symptoms Years in Advance
FNIH Biomarkers Consortium “clock model” can use a single blood test to estimate the onset of symptoms within three to four years
|5 min read
Global Neurodegeneration Proteomics Atlas Reveals Key Disease Signatures
A global harmonized proteomics dataset of Alzheimer’s, Parkinson’s, and FTD uncovers disease signatures to accelerate diagnostics and therapeutic discovery
|1 min read
Dried Blood Spot Testing Shows Early Promise for Alzheimer’s Biomarkers
Researchers report that dried blood spots can reliably measure p-tau217 and other Alzheimer’s biomarkers in a controlled research setting
|2 min read
Scientists Discover How Nanoplastics Disrupt Brain Energy Metabolism
The findings provide fresh insights into the potential health risks posed by environmental plastics
|4 min read
Roche Diagnostics Showcases AI, Digital Tools, and Clinical Innovation at ADLM 2025
At the ADLM 2025, Roche highlights advances in diagnostics, including digital health solutions, mass spectrometry, and expanded access to testing across care settings
Updated |2 min read
